🇺🇸 FDA
Company

VERTEX

VERTEX PHARMACEUTICALS INC / MA

VRTX pharma USA

Quick answer

VERTEX is a pharma company (VRTX) headquartered in BOSTON, MA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Biological/Vaccine

Type 1 Diabetes

Phase 3 · mab · active

1 trials project

CTX001

Beta-Thalassemia

Phase 3 · mab · active

1 trials project

ELX/TEZ/IVA

Cystic Fibrosis

Phase 3 · small_molecule · active

19 trials project

Exa-cel

Sickle Cell Disease

Phase 3 · mab · terminated

1 trials project

IVA

Cystic Fibrosis

Phase 3 · small_molecule · completed

3 trials project

Ivacaftor

Cystic Fibrosis

Phase 3 · small_molecule · completed

16 trials project

LUM

Cystic Fibrosis

Phase 3 · small_molecule · completed

1 trials project

Lumacaftor

Cystic Fibrosis

Phase 3 · small_molecule · completed

6 trials project

Lumacaftor Plus Ivacaftor Combination

Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation

Phase 3 · small_molecule · completed

1 trials project

Lumacaftor Plus Ivacaftor Combination

Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

Phase 3 · small_molecule · completed

1 trials project

MP-424

Chronic Hepatitis C

Phase 3 · small_molecule · completed

1 trials project

MP-424

Hepatitis C

Phase 3 · small_molecule · completed

2 trials project

Pegylated Interferon Alfa 2a

Infection

Phase 3 · small_molecule · terminated

1 trials project

Pegylated Interferon Alfa 2a

Hepatitis C

Phase 3 · mab · completed

1 trials project

Placebo

Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

Phase 3 · small_molecule · completed

1 trials project

Povetacicept

Primary Membranous Nephropathy

Phase 3 · small_molecule · active

1 trials project

Povetacicept

Immunoglobulin A Nephropathy

Phase 3 · small_molecule · active

1 trials project

Ribavirin

Genotype 1 Chronic Hepatitis C

Phase 3 · small_molecule · completed

1 trials project

SUZ

Acute Pain

Phase 3 · small_molecule · completed

1 trials project

Suzetrigine

Diabetic Peripheral Neuropathic Pain

Phase 3 · small_molecule · active

3 trials project

Suzetrigine (SUZ)

Acute Pain

Phase 3 · small_molecule · completed

1 trials project

TEZ

Cystic Fibrosis

Phase 3 · small_molecule · completed

2 trials project

TEZ/IVA

Cystic Fibrosis

Phase 3 · small_molecule · completed

3 trials project

Telaprevir

Hepatitis C, Chronic

Phase 3 · small_molecule · terminated

2 trials

Drugs (5)

drug

deutivacaftor

ALYFTREK

 drug

elexacaftor, ivacaftor, tezacaftor

TRIKAFTA (COPACKAGED)

 drug

ivacaftor

ORKAMBI

 drug

suzetrigine

JOURNAVX

 drug

telaprevir

INCIVEK

Patents (8)

patent

US 12421249

Inhibitors of APOL1 and methods of using same

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12421251

Cystic fibrosis transmembrane conductance regulator modulating agents

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12385013

Differentiation of pancreatic endocrine cells

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12384762

Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceut

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12384790

Pteridinone compounds and uses thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12377252

Implantation devices, system, and methods

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12371665

Differentiation of pancreatic endocrine cells

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350262

Methods of treatment for cystic fibrosis

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)